Vanda Pharmaceuticals Inc VNDA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
4.97quote price arrow up+0.09 (+1.84%)
Volume
48,745
Close
4.88quote price arrow up+0.20 (+4.27%)
Volume
623,930
52 week range
3.30 - 7.00
Loading...
  • Open4.71
  • Day High4.91
  • Day Low4.70
  • Prev Close4.68
  • 52 Week High7.00
  • 52 Week High Date05/05/23
  • 52 Week Low3.30
  • 52 Week Low Date11/10/23

Key Stats

  • Market Cap284.005M
  • Shares Out58.20M
  • 10 Day Average Volume1.32M
  • Dividend-
  • Dividend Yield-
  • Beta0.70
  • YTD % Change15.64

KEY STATS

  • Open4.71
  • Day High4.91
  • Day Low4.70
  • Prev Close4.68
  • 52 Week High7.00
  • 52 Week High Date05/05/23
  • 52 Week Low3.30
  • 52 Week Low Date11/10/23
  • Market Cap284.005M
  • Shares Out58.20M
  • 10 Day Average Volume1.32M
  • Dividend-
  • Dividend Yield-
  • Beta0.70
  • YTD % Change15.64

RATIOS/PROFITABILITY

  • EPS (TTM)0.04
  • P/E (TTM)111.16
  • Fwd P/E (NTM)-69.71
  • EBITDA (TTM)-10.942M
  • ROE (TTM)0.47%
  • Revenue (TTM)192.64M
  • Gross Margin (TTM)92.32%
  • Net Margin (TTM)1.30%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/08/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vanda Pharmaceuticals Inc

 

Profile

MORE
Vanda Pharmaceuticals Inc. is a biopharmaceutical company, which is focused on the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. The Company’s commercial portfolio is comprised of three products: HETLIOZ for the treatment of non-24-hour sleep-wake disorder (Non-24) and for the treatment of nighttime sleep disturbances in smith-magenis syndrome (SMS), Fanapt (iloperidone) for the treatment of bipolar I...
Mihael Polymeropoulos M.D.
Chairman of the Board, President, Chief Executive Officer
Kevin Moran
Chief Financial Officer, Senior Vice President, Treasurer
Address
SUITE 300E, 2200 PENNSYLVANIA AVE NW
Washington, DC
20037
United States

Top Peers

SYMBOLLASTCHG%CHG
AMRN
Amarin Corporation PLC
0.91-0.008-0.8715%
EGRX
Eagle Pharmaceuticals Inc
4.41+0.01+0.23%
TVTX
Travere Therapeutics Inc
6.26+0.10+1.62%
CSTL
Castle Biosciences Inc
24.33+1.49+6.52%
HROW
Harrow Inc
10.38-0.26-2.44%